Protara Therapeutics
TARA
TARA
80 hedge funds and large institutions have $114M invested in Protara Therapeutics in 2025 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 24 increasing their positions, 26 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
8% less repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 26
9.09% less ownership
Funds ownership: 77.02% → 67.93% (-9.1%)
30% less call options, than puts
Call options by funds: $183K | Put options by funds: $261K
Holders
80
Holding in Top 10
2
Calls
$183K
Puts
$261K
Top Buyers
| 1 | +$1.93M | |
| 2 | +$1.34M | |
| 3 | +$791K | |
| 4 |
Renaissance Technologies
New York
|
+$718K |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
+$559K |
Top Sellers
| 1 | -$3.39M | |
| 2 | -$3.15M | |
| 3 | -$2.59M | |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
-$2.58M |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$1.27M |
